51 – 93 of 93
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2019
-
Mark
Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
(
- Contribution to journal › Scientific review
-
Mark
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
2019) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 34(2). p.301-308(
- Contribution to journal › Article
-
Mark
PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
(
- Contribution to journal › Published meeting abstract
-
Mark
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Infections are associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis - a population-based case-control study from southern sweden
2019) The 19th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
- 2018
-
Mark
Hospitalizations due to systemic connective tissue diseases: : Secular trends and regional disparities in Sweden, 1998-2016
(
- Contribution to journal › Article
-
Mark
Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature
(
- Contribution to journal › Letter
-
Mark
Long-term outcomes of patients with Takayasu arteritis and renal artery involvement : A cohort study
(
- Contribution to journal › Article
-
Mark
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
(
- Contribution to journal › Article
-
Mark
Brief Report : Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
(
- Contribution to journal › Article
-
Mark
Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden
2018) American College of Rheumatology (ACR) Annual Meeting In Arthritis & Rheumatology 70(Suppl 9).(
- Contribution to journal › Published meeting abstract
-
Mark
Epidemiology of primary systemic vasculitis in children : a population-based study from southern Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
(
- Contribution to journal › Article
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis : The influence of ANCA subtype
(
- Contribution to journal › Article
-
Mark
Rate of comorbidities in giant cell arteritis : A population-based study
(
- Contribution to journal › Article
-
Mark
Large vessel involvement in biopsy-proven giant cell arteritis : incidence, distribution, and predictors
(
- Contribution to journal › Article
- 2016
-
Mark
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
(
- Contribution to journal › Article
-
Mark
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article
-
Mark
Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population
(
- Contribution to journal › Article
- 2015
-
Mark
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
(
- Contribution to journal › Scientific review
-
Mark
Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis.
(
- Contribution to journal › Article
-
Mark
Takayasu Arteritis in Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
(
- Contribution to journal › Article
-
Mark
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
(
- Contribution to journal › Article
- 2014
-
Mark
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis Versus Myeloperoxidase ANCA-associated Nephritis.
(
- Contribution to journal › Article
-
Mark
Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited.
(
- Contribution to journal › Article
- 2012
-
Mark
Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
- 2011
-
Mark
Association of cigarette smoking with organ damage in primary systemic vasculitis.
(
- Contribution to journal › Article
- 2009
-
Mark
Two episodes of digital vasculitis in a patient with rheumatoid arthritis (RA) treated with anti-tumor necrosis factor-alpha (TNF-alpha): case report
(
- Contribution to journal › Published meeting abstract
-
Mark
Two cases of Wegener's granulomatosis with unusual localization of granulomatous vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
Severe alpha 1-antitrypsin deficiency and primary systemic vasculitis revisited
(
- Contribution to journal › Published meeting abstract
-
Mark
Giant cell arteritis in patient with systemic sclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Studies on the Epidemiology and Outcome of Primary Systemic Vasculitis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
(
- Contribution to journal › Article
-
Mark
A comparison between biopsy-proven Lupus and ANCA-associated nephritis within a defined geographical area in southern Sweden
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
The incidence of renal vasculitis in southern Sweden
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.848-848(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden
(
- Contribution to journal › Article
- 2006
-
Mark
Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients.
(
- Contribution to journal › Article
- 2004
-
Mark
Pseudovaskulit - förvillande lik systemisk vaskulit ... men kräver helt annan behandling
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »